Andy Tompkins

Andy Tompkins, MD, MHS, is a Professor in the School of Medicine at the University of California, San Francisco (UCSF). His research focuses on substance-related disorders, chronic pain management, and behavioral pharmacology. He has secured substantial funding from NIH, SAMHSA, and private foundations for studies on opioid use disorder, cannabis interactions, and pain treatment optimization.

• BS, Biology/English - Emory University (1999)
• MD - New York Medical College (2004)
• Residency - Psychiatry, Johns Hopkins Hospital (2008)
• Post-doctoral Fellowship - Behavioral Pharmacology/Addictions, Johns Hopkins University (2010)
• MHS, Clinical Investigation - Johns Hopkins Bloomberg School of Public Health (2014)

Dr. Tompkins' research spans opioid pharmacology, chronic pain mechanisms, and addiction treatment. Recent publications analyze cannabis use in opioid recovery, yoga therapy for addiction, and sleep-pain interactions. His work appears in journals like JAMA Psychiatry, Addiction, and Pain.

Current projects include:

• Project JUNO Community (SAMHSA H79TI084269, 2021-2026) - Opioid use disorder treatment engagement
• NIH R21DA047520 (2019-2021) - Chronic pain impact on methadone patients
• Project HOUDINI LINK (SAMHSA H79TI081419-01, 2018-2021) - Opioid treatment initiation
• Site PI for CTN-0080 (NIH UG1DA015815, 2002-2025) - Medication treatment for pregnant opioid users

Dr. Tompkins collaborates with UCSF's Department of Psychiatry and the Drug and Social Addiction Medical Research (DSAAM) group. His methodological expertise includes clinical trials, observational studies, and behavioral economics.